Thomas Fischer

Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies

Daniel J. DeAngelo, Andrew Spencer, Kapil N. Bhalla et al. · Leukemia · 2013 · 138 citations

Medicine, Oncology, Pharmacology +17

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome‐negative cells

Michael W. Deininger, Jörge E. Cortes, Ron Paquette et al. · Cancer · 2007 · 129 citations · Full text

Medicine, Hematology, Oncology +16

Reassessment of sst₂Somatostatin Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-1

Thomas Fischer, Christian Doll, Stefan Jacobs et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 117 citations · Full text

Medicine, Endocrinology, Oncology +17

Evaluation of Late Results in Breast Reconstruction by Latissimus Dorsi Flap and Prosthesis Implantation

Ignazio Tarantino, Andrej Banič, Thomas Fischer · Plastic & Reconstructive Surgery · 2006 · 98 citations

Medicine, Plastic Surgery, Surgery +17

Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma

Michael Dickinson, David Ritchie, Daniel J. DeAngelo et al. · British Journal of Haematology · 2009 · 88 citations · Full text

Medicine, Oncology, Pharmacology +14